Which patient don't give calcium tablets
| Condition | Reason |
|---|---|
| Hypercalcemia | Calcium tablets will worsen already elevated serum calcium, risking cardiac arrhythmia, renal failure, and altered consciousness |
| Ventricular fibrillation | Calcium chloride/acetate is specifically contraindicated in VF (The Harriet Lane Handbook) |
| Hypercalciuria | Excess urinary calcium raises risk of calcium oxalate or calcium phosphate kidney stones |
| Hypersensitivity to calcium salts | Allergic reactions |
| Condition | Reason |
|---|---|
| Sarcoidosis | Activated macrophages in granulomas produce excess 1,25-dihydroxyvitamin D (calcitriol), which already increases calcium absorption - extra calcium can precipitate severe hypercalcemia |
| End-stage renal failure (CKD stage 5) | Impaired calcium excretion leads to accumulation and hypercalcemia; The Harriet Lane Handbook explicitly warns against use in ESRD |
| Primary hyperparathyroidism | PTH already drives calcium levels up; supplemental calcium worsens hypercalcemia |
| Malignancy with bone metastases or humoral hypercalcemia | Tumors (especially multiple myeloma, breast cancer, lung cancer, PTHrP-secreting tumors) cause hypercalcemia - calcium tablets are contraindicated |
| Vitamin D toxicity | Excess vitamin D maximally upregulates intestinal calcium absorption; additional calcium intake causes dangerous hypercalcemia |
| Calcium oxalate kidney stones (idiopathic hypercalciuria) | High calcium intake raises urinary calcium and promotes stone formation (note: enteric oxaluria is an exception where calcium is actually used - Katzung's Pharmacology) |
| Thiazide diuretic use | Thiazides reduce renal calcium excretion; combining with calcium supplements significantly raises hypercalcemia risk (milk-alkali syndrome) |
| Digoxin therapy | Calcium potentiates digoxin toxicity and can precipitate fatal arrhythmias - The Harriet Lane Handbook notes this interaction for calcium acetate and calcium chloride |
| Patients on fluoroquinolones, tetracyclines, or iron | Calcium chelates these drugs and markedly reduces their absorption |
"HSVMDR" - Hypercalcemia, Sarcoidosis, Ventricular fibrillation, Malignancy with bone mets, Digoxin use, Renal failure (ESRD)